Ozempic Fears Hammer DexCom Stock. The Concerns Are Overblow

Worries that new weight loss drugs will impact demand for continuous glucose monitoring devices have gone too far.

Related Keywords

Matthew Taylor , Marie Thibault , , Courtesy Dexcom , Novo Nordisk , Abbott Laboratories , Article Normal , Medical Equipment Supplies , Healthcare Life Sciences , Financial Performance , Corporate Industrial News , Political General News , Diabetes , Health , Medical Conditions , Content Types , Factiva Filters , C Amp Ampe Industry News Filter , Synd , Healthcare , Magazine , Dexcom , Dxcm , Abt , Novob Ko , Nvo , Corporate , Industrial News , Political , General News , Medical Equipment , Supplies , Life Sciences ,